Johnson & Johnson has appointed Thibaut Mongon as the chief executive of its consumer health division, which is scheduled to be spun off into a listed company by the end of 2023.
GlaxoSmithKline's consumer health business will be named Haleon following its planned spinoff and listing on the London Stock Exchange later this year, according to the drugmaker.<
Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year.
After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operation
